Hypertension in patients with diabetes: Strategies for drug therapy to reduce complications
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Hypertension in diabetic patients must be treated aggressively if patients are to benefit from reduced risk of morbidity and mortality. Diabetes itself must be diagnosed promptly, particularly in at-risk patients, so appropriate lifestyle modifications can be made at the earliest opportunity. Although this may reduce or delay onset of hypertension, antihypertensive drug treatment should be initiated in the diabetic patient with even high-normal blood pressure. Traditional approaches to management of hypertension are inappropriate for most patients with diabetes. While ACE inhibitors, calcium antagonists, angiotensin II receptor blockers, beta blockers, and low-dose diuretics, alone or in combination, all currently have roles in hypertension management, the outcomes of studies now under way may clarify some still unanswered questions about the dangerous combination of high blood pressure and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bakris, G. L., Copley, J. B., Vicknair, N., Sadler, R., & Leurgans, S. (1996) · Kidney International · doi:10.1038/ki.1996.480 · Cited by 417
Self-citationRizzo, J. A., & Robert Simons, W. (1997) · Clinical Therapeutics · doi:10.1016/s0149-2918(97)80018-5 · Cited by 174
Research works printed but not linked: 16
- Hansson L, 1998, Lancet, 351, 1755, 10.1016/S0140-6736(98)04311-6 · DOI · Paper page
- UK Prospective Diabetes Study (UKPDS) Group., 1998, BMJ, 317, 703, 10.1136/bmj.317.7160.703 · DOI · Paper page
- Flack JM, 1999, J Hypertens, 17, S19, 10.1097/00004872-199917010-00004 · DOI
- Teuscher AU, 1997, J Hypertens, 15, S67, 10.1097/00004872-199715022-00006 · DOI
- American Diabetes Association., 2000, Diabetes Care, 23, S4
- Lewis EJ, 1993, N Engl J Med, 329, 1456, 10.1056/NEJM199311113292004 · DOI · Paper page
- Bakris GL, 1997, Hypertension, 29, 744, 10.1161/01.HYP.29.3.744 · DOI · Paper page
- Chaiken RL, 1995, Kidney Int, 47, 1697, 10.1038/ki.1995.235 · doi:10.1038/ki.1995.235
- Bakris G, 1997, J Human Hypertens, 11, 35, 10.1038/sj.jhh.1000398 · DOI
- Epstein M, 1969, Arch Intern Med 1996, 156
- Bakris GL, 1998, Kidney Int, 54, 1283, 10.1046/j.1523-1755.1998.00083.x · DOI · Paper page
- Bretzel RG., 1997, Am J Hypertens, 10, 208S, 10.1016/S0895-7061(97)00155-6 · DOI
- Flack JM, 1997, J Human Hypertens, 11, 23, 10.1038/sj.jhh.1000396 · doi:10.1038/sj.jhh.1000396
- Plat F, 1997, Am J Hypertens, 10, 262S, 10.1016/S0895-7061(97)00333-6 · doi:10.1016/s0895-7061(97)00333-6
- Makrilakis K, 1998, J Cardiovasc Pharmacol, 31, S34, 10.1097/00005344-199800002-00006 · DOI
- Schneider M, 1996, J Hypertens, 14, 669, 10.1097/00004872-199605000-00018 · DOI
Cited by
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Handelsman, Y., Mechanick, J. I., Blonde, L., Grunberger, G., Bloomgarden, Z. T., Bray, G. A., Dagogo-Jack, S., Davidson, J. A., Einhorn, D., Ganda, O., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.s2.1 · Cited by 513
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Metadata
- Authors
- Sowers, J. R., Williams, M., Epstein, M., & Bakris, G.
- Venue
- Postgraduate Medicine
- Publisher
- Informa UK Limited
- Published
- 2000-04
- Volume
- 107
- Issue
- 4
- Pages
- 47-60
- ISSN
- 0032-5481 (ISSN-L)
- 1941-9260
- OpenAlex
- W1992157961
- Cited by
- 34
- References
- 2
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypertension in patients with diabetes: Strategies for drug therapy to reduce complications. https://app.cochat.ai/papers/10.3810/pgm.2000.04.990
- The paper
- Sowers, J. R., Williams, M., Epstein, M., & Bakris, G. (2000). Hypertension in patients with diabetes: Strategies for drug therapy to reduce complications. Postgraduate Medicine. https://doi.org/10.3810/pgm.2000.04.990
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.